US 8771696
Method of reducing the severity of stress hyperglycemia with human antibodies to the glucagon receptor
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 8771696 (Method of reducing the severity of stress hyperglycemia with human antibodies to the glucagon receptor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K38/28, A61K39/39541